Voyager Therapeutics GAAP EPS of -$0.57 misses by $0.04, revenue of $5.2M misses by $4.3M
Source: SeekingAlpha
2025-08-06 17:20:19 ET
More on Voyager Therapeutics
- Voyager Therapeutics: Navigating AAV Headwinds And A Long Road For VY7523 (Downgrade)
- Seeking Alpha’s Quant Rating on Voyager Therapeutics
- Historical earnings data for Voyager Therapeutics
- Financial information for Voyager Therapeutics
Read the full article on Seeking Alpha
For further details see:
Voyager Therapeutics GAAP EPS of -$0.57 misses by $0.04, revenue of $5.2M misses by $4.3M
Voyager Therapeutics Inc.
NASDAQ: VYGR
VYGR Trading
20.25% G/L:
$4.90 Last:
3,390,448 Volume:
$4.11 Open:
VYGR Latest News
March 09, 2026 04:01:00 pm
Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
VYGR Stock Data
$301,853,951
50,692,821
0.13%
37
N/A
Biotechnology & Life Sciences
Healthcare
US
Lexington
